arrow
A

Antonino Musolino

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori
H指数:34
被引数:5,168

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association between chemotherapy use and prognosis in young patients with stage I-II ER+/HER2-negative breast cancer according to Prosigna®: an international real-world analysis with propensity-score matching

根据Prosigna®评估年轻患者中I-II期ER+/HER2阴性乳腺癌化疗使用与预后的关联:一项基于倾向性评分匹配的国际真实世界分析

2026-05-220
OAAI
Survey on cancer patients’ attitudes towards AI and data protection: A cross-sectional study from an Italian cancer center

关于癌症患者对人工智能和数据保护态度的调查研究:一项来自意大利癌症中心的研究

2025-12-300
PRE
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications

Basal-like HR⁺/HER2⁻乳腺癌显示出更高的肿瘤浸润淋巴细胞和免疫特征,具有潜在的治疗意义。

2025-12-240
OAAI
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial☆

肿瘤浸润淋巴细胞与BMI在早期HER2阳性乳腺癌中的相互作用:ShortHER试验分析☆

2025-10-100
OAAI
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients

A-BRAVE试验:一项使用抗PD-L1药物avelumab治疗高风险三阴性早期乳腺癌患者的III期随机试验

2025-08-280
OAAI
PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)]

意大利乳腺癌患者预测性BRCA基因检测:意大利科学学会立场文件[意大利医学肿瘤学会(AIOM);意大利放射治疗与临床肿瘤学会 (AIRO);意大利全国乳腺外科医师协会 (ANISC);意大利病理解剖学与诊断细胞学学会 (SIAPeC-IAP);意大利外科肿瘤学会 (SICO);意大利人类遗传学会 (SIGU);意大利全科医学学会 (SIMG);意大利医学与介入放射学学会 (SIRM)]

2025-06-150
PREAI
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants

探索三阴性乳腺癌患者中癌症易感基因的启动子区域,发现存在罕见的胚系变异。

2025-05-080
OA
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy

SARS-CoV-2感染风险及COVID-19患病率与死亡率:意大利北部疫情中心第一波COVID-19大流行期间癌症患者研究

CANCERS
IF4.4
2025-05-010
OA
Hormonal Therapy In Endometriosis And Breast Cancer Risk Propensity Score-Matched Real-World Analysis

子宫内膜异位症中的激素疗法与乳腺癌风险倾向评分匹配的真实世界分析

2025-02-010
PRE
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial
2025-01-011
OAAI
Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030
2024-07-014
OAAI
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study
2024-05-141
PRE
CDK4/6 inhibitors in advanced breast cancer (aBC). Preliminary results of the CDK4/6i choice and sequence of treatments in a series of 174 patients. GOIRC-04-2019 retro/prospective observational study
2024-05-020
PRE